LINEO THAHANE to Male
This is a "connection" page, showing publications LINEO THAHANE has written about Male.
Connection Strength
0.071
-
Tolerability of lopinavir versus dolutegravir in children and adolescents with HIV. AIDS. 2026 May 01; 40(5):600-610.
Score: 0.010
-
HIV drug resistance amongst children and adolescents with viraemia in Lesotho and Tanzania: a nested analysis in the GIVE MOVE trial. J Antimicrob Chemother. 2026 Mar 04; 81(4).
Score: 0.010
-
A 4-Year Residency Program in Pediatrics/Global Child Health. Pediatrics. 2025 Aug 01; 156(2).
Score: 0.009
-
Resistance-informed versus empirical management of viraemia in children and adolescents with HIV in Lesotho and Tanzania (GIVE MOVE trial): a multisite, open-label randomised controlled trial. Lancet Glob Health. 2024 08; 12(8):e1312-e1322.
Score: 0.009
-
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study. Lancet Glob Health. 2024 06; 12(6):e929-e937.
Score: 0.009
-
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc. 2022 03; 25(3):e25871.
Score: 0.007
-
Pediatric Hospital Medicine and Global Health: A Fitting Niche for an Emerging Subspecialty. Am J Trop Med Hyg. 2021 09 07; 105(5):1152-1154.
Score: 0.007
-
Genotype-Informed Versus Empiric Management Of VirEmia (GIVE MOVE): study protocol of an open-label randomised clinical trial in children and adolescents living with HIV in Lesotho and Tanzania. BMC Infect Dis. 2020 Oct 19; 20(1):773.
Score: 0.007
-
Mortality and clinical outcomes in HIV-infected children on antiretroviral therapy in Malawi, Lesotho, and Swaziland. Pediatrics. 2012 Sep; 130(3):e591-9.
Score: 0.004